Prof James Flanagan, completed his PhD in 2002 at the Queensland Institute of Medical Research in Brisbane, Australia, and has pursued postdoctoral work in Cancer Genetics, Epigenetics and Cancer Epigenetics. He started at Imperial College in 2009 as a Breast Cancer Campaign Scientific Fellow (Imperial, 2009-2014) and in 2024 was appointed Professor of Cancer Informatics in the Division of Cancer, Dept. of Surgery and Cancer, Faculty of Medicine at Imperial College London. He was awarded the British Association of Cancer Research Translational Researcher Award in 2011 and the prestigious DataIQ award in 2023 for his work using Shopping Loyalty Cards for early detection of ovarian cancer. He is the principal investigator (PI) for the CRUK funded project "Cancer Loyalty Card Study (CLOCS)". His research focusses on translational epigenomics and digital health.